Edition:
United States

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

5.59USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$5.59
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,434
52-wk High
$39.00
52-wk Low
$4.99

Chart for

About

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $33.02
Shares Outstanding(Mil.): 5.67
Dividend: --
Yield (%): --

Financials

  ONTX.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -25.91 -- --
ROI: -177.07 13.18 12.83
ROE: -294.42 15.14 14.95

BRIEF-Onconova Therapeutics Reports Q1 Loss Per Share Of $0.34

* ONCONOVA THERAPEUTICS, INC. REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR FIRST QUARTER 2018

May 15 2018

BRIEF-Oleg Nodelman Reports 9.99 Pct Passive Stake In Onconova Therapeutics As Of April 27, 2018

* OLEG NODELMAN REPORTS 9.99 PERCENT PASSIVE STAKE IN ONCONOVA THERAPEUTICS INC, AS OF APRIL 27, 2018 - SEC FILING Source text: (https://bit.ly/2KJY3o0) Further company coverage:

May 07 2018

BRIEF-Onconova Therapeutics Announces Pricing Of $25 Mln Upsized Underwritten Public Offering

* ONCONOVA THERAPEUTICS ANNOUNCES PRICING OF $25.0 MILLION UPSIZED UNDERWRITTEN PUBLIC OFFERING

Apr 27 2018

Earnings vs. Estimates